Background: Extracorporeal membrane oxygenation (ECMO) is frequently used during lung transplantation. Unfractionated heparin (UFH) is mainly used as part of ECMO support for anticoagulation. One of the most common perioperative complications is bleeding, which high-dose UFH can aggravate. Methods: We retrospectively analyzed (n = 141) patients who underwent lung transplantation between 2020 and 2022. All subjects (n = 109) underwent central cannulated VA ECMO with successful intraoperative ECMO weaning. Patients on ECMO bridge, postoperative ECMO, heart-lung transplants and transplants without ECMO were excluded. The dose of UFH for the entire surgical procedure, blood loss and consumption of blood derivatives intraoperatively and 48 h after ICU admission were recorded. Surgical revision for postoperative bleeding were analyzed. Thrombotic complications, mortality and long-term survival were evaluated. Results: Lower doses of UFH administered for intraoperative ECMO anticoagulation contribute to a reduction in intraoperative blood derivates consumption and blood loss with no thrombotic complications related to the patient or the ECMO circuit. Lower doses of UFH may lead to a decreased incidence of surgical revision for hemothorax. Conclusion: Lower doses of UFH as part of intraoperative ECMO anticoagulation might reduce the incidence of complications and lead to better postoperative outcomes.

Department of Anaesthesiology Resuscitation and Intensive Care Medicine 2nd Faculty of Medicine Charles University University Hospital in Motol Prague Czechia

Prague Lung Transplant Program 3rd Department of Surgery 1st Faculty of Medicine Charles University University Hospital in Motol Prague Czechia

Zobrazit více v PubMed

Hartwig M, van Berkel V, Bharat A, Cypel M, Date H, Erasmus M, et al. The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: The Use of Mechanical Circulatory Support in Lung Transplantation. J Thorac Cardiovasc Surg (2023) 165(1):301–26. 10.1016/j.jtcvs.2022.06.024 PubMed DOI

Moreno Garijo J, Cypel M, McRae K, Machuca T, Cunningham V, Slinger P. The Evolving Role of Extracorporeal Membrane Oxygenation in Lung Transplantation: Implications for Anesthetic Management. J Cardiothorac Vasc Anesth (2019) 33(7):1995–2006. 10.1053/j.jvca.2018.10.007 PubMed DOI

Thomas M, Martin AK, Allen WL, Makey IA, Renew JR, Rodrigues ES, et al. Lung Transplantation Using a Hybrid Extracorporeal Membrane Oxygenation Circuit. ASAIO J Am Soc Artif Intern Organs (2020) 66(10):e123–5. 10.1097/MAT.0000000000001157 PubMed DOI

Hoetzenecker K, Benazzo A, Stork T, Sinn K, Schwarz S, Schweiger T, et al. Bilateral Lung Transplantation on Intraoperative Extracorporeal Membrane Oxygenator: An Observational Study. J Thorac Cardiovasc Surg (2020) 160(1):320–7.e1. 10.1016/j.jtcvs.2019.10.155 PubMed DOI

Martin AK, Yalamuri SM, Wilkey BJ, Kolarczyk L, Fritz AV, Jayaraman A, et al. The Impact of Anesthetic Management on Perioperative Outcomes in Lung Transplantation. J Cardiothorac Vasc Anesth (2020) 34(6):1669–80. 10.1053/j.jvca.2019.08.037 PubMed DOI

Loor G, Huddleston S, Hartwig M, Bottiger B, Daoud D, Wei Q, et al. Effect of Mode of Intraoperative Support on Primary Graft Dysfunction After Lung Transplant. J Thorac Cardiovasc Surg (2022) 164(5):1351–61.e4. 10.1016/j.jtcvs.2021.10.076 PubMed DOI

Porteous MK, Diamond JM, Christie JD. Primary Graft Dysfunction: Lessons Learned About the First 72 h After Lung Transplantation. Curr Opin Organ Transpl (2015) 20(5):506–14. 10.1097/MOT.0000000000000232 PubMed DOI PMC

George PM, Patterson CM, Reed AK, Thillai M. Lung Transplantation for Idiopathic Pulmonary Fibrosis. Lancet Respir Med (2019) 7(3):271–82. 10.1016/S2213-2600(18)30502-2 PubMed DOI

Chicotka S, Pedroso FE, Agerstrand CL, Rosenzweig EB, Abrams D, Benson T, et al. Increasing Opportunity for Lung Transplant in Interstitial Lung Disease With Pulmonary Hypertension. Ann Thorac Surg (2018) 106(6):1812–9. 10.1016/j.athoracsur.2018.04.068 PubMed DOI

Aubron C, DePuydt J, Belon F, Bailey M, Schmidt M, Sheldrake J, et al. Predictive Factors of Bleeding Events in Adults Undergoing Extracorporeal Membrane Oxygenation. Ann Intensive Care (2016) 6(1):97. 10.1186/s13613-016-0196-7 PubMed DOI PMC

Bartlett R, Arachichilage DJ, Chitlur M, Hui SKR, Neunert C, Doyle A, et al. The History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation. Semin Thromb Hemost (2023) 50:81–90. 10.1055/s-0043-1761488 PubMed DOI

Olson SR, Murphree CR, Zonies D, Meyer AD, Mccarty OJT, Deloughery TG, et al. Thrombosis and Bleeding in Extracorporeal Membrane Oxygenation (ECMO) Without Anticoagulation: A Systematic Review. ASAIO J Am Soc Artif Intern Organs (2021) 67(3):290–6. 10.1097/MAT.0000000000001230 PubMed DOI PMC

Rajsic S, Breitkopf R, Oezpeker UC, Bukumirić Z, Dobesberger M, Treml B. The Role of Excessive Anticoagulation and Missing Hyperinflammation in ECMO-Associated Bleeding. J Clin Med (2022) 11(9):2314. 10.3390/jcm11092314 PubMed DOI PMC

Fessler J, Finet M, Fischler M, Le Guen M. New Aspects of Lung Transplantation: A Narrative Overview Covering Important Aspects of Perioperative Management. Life Basel Switz (2022) 13(1):92. 10.3390/life13010092 PubMed DOI PMC

Martin AK, Reed AK, Hoetzenecker K, Fessler J. How We Would Treat Our Own Lung Transplantation: A Multidisciplinary and International Perspective. J Cardiothorac Vasc Anesth (2023) 37:2207–14. 10.1053/j.jvca.2023.07.042 PubMed DOI

McMichael ABV, Ryerson LM, Ratano D, Fan E, Faraoni D, Annich GM. 2021 ELSO Adult and Pediatric Anticoagulation Guidelines. ASAIO J Am Soc Artif Intern Organs (2022) 68(3):303–10. 10.1097/MAT.0000000000001652 PubMed DOI

Vajter J, Garaj M, Lischke R, Durila M. (710) Bolus Dosage of Heparin According to ACT Versus Continuous Dosage of Heparin According to ROTEM for ECMO Anticoagulation in Lung Transplantation - Effect on Perioperative Blood Loss. J Heart Lung Transpl (2023) 42(4):S314–5. 10.1016/j.healun.2023.02.724 DOI

Kumar G, Maskey A. Anticoagulation in ECMO Patients: An Overview. Indian J Thorac Cardiovasc Surg (2021) 37(2):241–7. 10.1007/s12055-021-01176-3 PubMed DOI PMC

Rajsic S, Breitkopf R, Jadzic D, Popovic Krneta M, Tauber H, Treml B. Anticoagulation Strategies During Extracorporeal Membrane Oxygenation: A Narrative Review. J Clin Med (2022) 11(17):5147. 10.3390/jcm11175147 PubMed DOI PMC

Bernhardt AM, Copeland H, Deswal A, Gluck J, Givertz MM, Task Force 1. The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support. J Card Fail (2023) 29(3):304–74. 10.1016/j.cardfail.2022.11.003 PubMed DOI

Lorusso R, Whitman G, Milojevic M, Raffa G, McMullan DM, Boeken U, et al. 2020 EACTS/ELSO/STS/AATS Expert Consensus on Post-Cardiotomy Extracorporeal Life Support in Adult Patients. Eur J Cardio-thorac Surg Off J Eur Assoc Cardio-thorac Surg (2021) 59(1):12–53. 10.1093/ejcts/ezaa283 PubMed DOI

Garaj M, Durila M, Vajter J, Solcova M, Marecek F, Hrachovinová I. Extracorporeal Membrane Oxygenation Seems to Induce Impairment of Primary Hemostasis Pathology as Measured by a Multiplate Analyzer: An Observational Retrospective Study. Artif Organs (2022) 46(5):899–907. 10.1111/aor.14142 PubMed DOI

Durila M, Vajter J, Garaj M, Pollert L, Berousek J, Vachtenheim J, Jr, et al. Rotational Thromboelastometry Reduces Blood Loss and Blood Product Usage After Lung Transplantation. J Heart Lung Transpl Off Publ Int Soc Heart Transpl (2021) 40(7):631–41. 10.1016/j.healun.2021.03.020 PubMed DOI

Vajter J, Vachtenheim J, Prikrylova Z, Berousek J, Vymazal T, Lischke R, et al. Effect of Targeted Coagulopathy Management and 5% Albumin as Volume Replacement Therapy During Lung Transplantation on Allograft Function: A Secondary Analysis of a Randomized Clinical Trial. BMC Pulm Med (2023) 23(1):80. 10.1186/s12890-023-02372-0 PubMed DOI PMC

Anticoagulation Management During ECMO: Narrative Review